The clinical Phase 2b study of its novel Rivelin patch to be tested in patients suffering from Oral Lichen Planus.
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Clobetasol (Primary)
- Indications Lichen planus
- Focus Therapeutic Use
- 22 Jan 2018 New trial record
- 11 Jan 2018 According to a Dermtreat media release, the study is expected to last for 6-9 months with study results being available in 1H 2019.
- 11 Jan 2018 According to a Dermtreat media release, dermtreat has finalized and submitted the IND and CTAs respectively to commence this Phase 2b clinical study with the first patient planned to be enrolled in April 2018..